Search

Search Constraints

You searched for: Author/Creator Calvo, X.

Search Results

1. 144 CSF3R POINT MUTATIONS IN A COHORT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) AND NEUTROPENIA AT DIAGNOSIS. (April 2015)

2. 260 CONSIDERING PERCENTAGE OF BLASTS ON THE BASIS OF NON-ERYTHROID COMPARTMENT MIGHT IMPROVE THE CLASSIFICATION AND PROGNOSTICATION OF MDS WITH EXCESS OF BLAST CELLS. Issue 1 (April 2015)

3. 261 ERYTHROLEUKEMIA APPEARS TO BE A CONTINUUM OF MDS WITH ERYTHROID HYPERPLASIA AND SHARES OUTCOME AND CYTOGENETIC FEATURES WITH RAEB-1 WITH ≥50% ERYTHROPOIESIS. Issue 1 (April 2015)

4. Calculating IPSS-R by Enumerating Bone Marrow Blasts from Nonerythroid Cellularity Improves Outcome Prediction in MDS with Erythroid Predominance. (April 2017)

6. Clinical and Biological Significance of Y Chromosome Loss in a Series of 2, 423 Male Patients with MDS and CMML. (April 2017)

7. Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale. Issue 5 (September 2015)

8. Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome. Issue 208 (December 2021)

9. The Prognostic Evaluation of Myelodysplastic Syndromes with Ring Sideroblasts can be Improved by Considering Bone Marrow Blasts from Nonerythroid Cells. (April 2017)

10. Topic: AS02-Epidemiology: COMPARISON OF CYTOGENETIC ABERRATIONS IN 1590 PATIENTS WITH THERAPY-RELATED MDS (T-MDS) AND 4738 PATIENTS FROM THE REVISED INTERNATIONAL PROGNOSTIC SCORING SYSTEM DATABASE WITH PRIMARY-MDS (P-MDS). (September 2021)